🕵️ Corvus Pharmaceuticals, Inc. ($CRVS)
SEC insider & ownership activity, last 12 months · CIK 1626971 · every row links its SEC filing
Over the last 12 months insiders bought $334K with no open-market selling against it. Moore David Scott bought $250K in discretionary trades (Jun). Orbimed Advisors LLC trimmed 12.2% → 10.3%; Orbimed Capital GP V LLC trimmed 12.2% → 10.3%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $334K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Moore David Scott | 1 | $250K | 0 | – | Jun 11, 2026 |
| Miller Richard A Md | 2 | $83K | 0 | – | May 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 10.3% | 13D | Jan 23, 2026 | filing ↗ | |
| Orbimed Capital GP V LLC | 10.3% | 13D | Jan 23, 2026 | filing ↗ | |
| Samlyn Capital, LLC | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Samlyn, LP | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Robert Pohly | 9.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Richard A. Miller | 7.8% | 13G | Feb 13, 2026 | filing ↗ | |
| Blackrock, Inc. | 7.5% | 13G | Jul 27, 2026 | filing ↗ | |
| Sirenia Capital Management LP | 7.5% | 13G | May 15, 2026 | filing ↗ | |
| Alex Silverstein | 7.5% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 14, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 21, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 20, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 2, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |